Skip to content
TrialScanner

NCT04538989

An Open-Label Multiple Dose Study of RZ358 in Patients With Congenital Hyperinsulinism

Phase 2CompletedRZLTLead

Registry record

Lead sponsor
Rezolute
Conditions
Congenital Hyperinsulinism
Primary completion
Apr 5, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04538989 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04538989: An Open-Label Multiple Dose... | TrialScanner